Compare ABCL & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | LWLG |
|---|---|---|
| Founded | 2012 | 1991 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 2011 |
| Metric | ABCL | LWLG |
|---|---|---|
| Price | $7.87 | $9.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.40 | N/A |
| AVG Volume (30 Days) | ★ 7.1M | 5.6M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 15.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,128,000.00 | $236,855.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.85 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 160.56 | 147.74 |
| 52 Week Low | $2.75 | $1.26 |
| 52 Week High | $8.42 | $18.71 |
| Indicator | ABCL | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 73.27 | 45.63 |
| Support Level | $3.32 | $8.83 |
| Resistance Level | N/A | $10.58 |
| Average True Range (ATR) | 0.53 | 0.78 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 83.58 | 61.44 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.